Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126963281 | 12696328 | 1 | I | 201410 | 20160823 | 20160830 | 20160830 | EXP | DE-ORION CORPORATION ORION PHARMA-TREX2016-1439 | ORION | KRUGER T,JOCKERS-SCHERUBL M. DEVELOPMENT OF EPILEPTIC SEIZURES UNDER THERAPY WITH OLANZAPINE AND VENLAFAXINE ER WITH FATAL OUTCOME. PSYCHOPHARMAKOTHERAPIE. 2016;23(3):125-8. | 76.00 | YR | F | Y | 0.00000 | 20160830 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126963281 | 12696328 | 1 | PS | METHOTREXATE. | METHOTREXATE | 1 | Oral | U | 0 | 15 | MG | /wk | |||||||
| 126963281 | 12696328 | 2 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | U | 0 | 5 | MG | ||||||||
| 126963281 | 12696328 | 3 | SS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | U | 0 | 110 | MG | BID | |||||||
| 126963281 | 12696328 | 4 | SS | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | U | 0 | 37.5 | MG | EXTENDED RELEASE | |||||||
| 126963281 | 12696328 | 5 | SS | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | Unknown | U | 0 | 75 | MG | EXTENDED RELEASE | |||||||
| 126963281 | 12696328 | 6 | SS | OLANZAPINE. | OLANZAPINE | 1 | Oral | U | 0 | 5 | MG | ||||||||
| 126963281 | 12696328 | 7 | SS | OLANZAPINE. | OLANZAPINE | 1 | Unknown | U | 0 | 2.5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126963281 | 12696328 | 1 | Rheumatoid arthritis |
| 126963281 | 12696328 | 2 | Rheumatoid arthritis |
| 126963281 | 12696328 | 3 | Deep vein thrombosis |
| 126963281 | 12696328 | 4 | Antidepressant therapy |
| 126963281 | 12696328 | 6 | Insomnia |
| 126963281 | 12696328 | 7 | Affective disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126963281 | 12696328 | DE |
| 126963281 | 12696328 | HO |
| 126963281 | 12696328 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126963281 | 12696328 | Circulatory collapse | |
| 126963281 | 12696328 | Depression | |
| 126963281 | 12696328 | Femoral neck fracture | |
| 126963281 | 12696328 | General physical health deterioration | |
| 126963281 | 12696328 | Generalised tonic-clonic seizure | |
| 126963281 | 12696328 | Haematoma | |
| 126963281 | 12696328 | Iron deficiency anaemia | |
| 126963281 | 12696328 | Joint stiffness | |
| 126963281 | 12696328 | Osteoporosis | |
| 126963281 | 12696328 | Patella fracture | |
| 126963281 | 12696328 | Tibia fracture | |
| 126963281 | 12696328 | Ulna fracture |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |